Description
Tesamorelin is a synthetic 44-amino-acid analogue of GHRH with a trans-3-hexenoic acid group conjugated to the N-terminus for stability; it acts biochemically as a GHRH-receptor agonist. It was previously approved as a pharmaceutical (marketed as Egrifta) and is supplied here solely as a lyophilized research chemical.
Research context: In published laboratory and preclinical research, tesamorelin has been studied in the context of GHRH-receptor signaling and lipid and metabolic pathways.
Specifications: Molecular mass 5135.85 Da; CAS 218949-48-5; purity ≥98% (HPLC); 10 mg lyophilized powder in a sealed vial; storage −20°C (24 months).
This product is supplied strictly for in-vitro laboratory research. It is not a drug, food, cosmetic, or dietary supplement, and is not intended for human or animal consumption, medical, veterinary, or household use.
Reviews
There are no reviews yet.